Go Green Project X — Nea Penteli

Care at Go Green Project X — Nea Penteli

Go Green Project X and The Cannabis Project

Go Green Project X is the name used by the Recovery.com directory listing for a program in Nea Penteli, Greece. The provider website linked from that listing is branded The Cannabis Project. It advertises a recovery program using medical cannabis alongside other support. This is a distinctive treatment proposition that needs careful discussion with a qualified clinician. The shared website link does not by itself establish a legal trading-name history, current facility licence, or the qualifications of the professionals who would be responsible for a particular admission.

The program appears in the Greece treatment directory. Its official website refers to a residential retreat in Greece, but the pages reviewed did not provide a current street address or a named local clinical roster. Nea Penteli is therefore retained as the location reported by the secondary listing, with the exact operating address requiring confirmation. Before planning travel, request the residence address, the name of the contracting organization, and the identity of the clinician assessing eligibility. Those details are necessary to understand what is being offered at the actual destination.

Understanding the advertised model

The Cannabis Project’s homepage describes cannabis use within addiction detoxification and treatment, along with medical and nursing care, psychotherapy, groups, exercise, and other activities. The same page uses both inpatient and outpatient language. Ask the team to resolve that distinction in a written explanation of the proposed program. Where will you sleep, where are clinical appointments delivered, and which professionals are physically present overnight? A retreat, an outpatient clinic with accommodation, and a medically staffed residential service involve different arrangements. The advertisement alone does not establish which model would apply to the person making an inquiry.

The provider’s FAQ says cannabis is administered in forms such as oils, tablets, or edibles rather than by smoking. It also discusses stays of differing lengths and continuing support afterward. These are descriptions supplied by the business, not a prescription or evidence that a particular product is appropriate. If a cannabis-based intervention is proposed, ask the responsible physician to identify the exact product, its purpose, the assessment supporting its use, and how benefits and adverse effects would be monitored. The answers should be specific to the person and their existing treatment.

Evaluating medical claims without relying on slogans

The website makes strong claims about cannabis and addiction. Clinical Recovery does not treat those claims as established results for this program. Evidence about a particular cannabinoid, dose, diagnosis, or short-term outcome cannot automatically support claims about every cannabis preparation or long-term recovery. Ask for the studies relevant to the exact intervention being proposed and review them with an independent clinician familiar with your history. An explanation of the limitations is as useful as a description of possible benefits. Testimonials and a confident marketing phrase cannot establish an individual treatment’s effectiveness or suitability.

For context, the US Food and Drug Administration distinguishes cannabis from the specific cannabis-derived or cannabis-related drug products it has approved for particular indications. This US regulatory information does not determine Greek prescribing rules or the status of this provider. It does illustrate why the phrase medical cannabis should not be read as universal approval for every claimed use. Ask the Greek prescriber to explain the applicable local authorization, the proposed indication, and how the treatment compares with other options that may be available for the same condition.

If you already receive treatment for substance use or a mental health condition, involve the current treating professional in the discussion. Do not stop prescribed medication or replace an established care plan solely because a different program advertises a new approach. Ask how The Cannabis Project would coordinate with existing clinicians and what happens if the proposed intervention is declined or found unsuitable. A useful decision process includes alternatives, the expected monitoring, and a plan for changing course. It should leave the prospective resident able to understand the choices rather than feeling that one advertised method is the only route forward.

Assessment and clinical responsibility

The official admissions form asks about health conditions, medications, allergies, prior medical contact, and an emergency contact. Completing a form is only an initial information-gathering step. Before sending sensitive records, confirm who will review them and how the clinical assessment will take place. Ask for the name and professional registration of the prescribing clinician, the role of other staff, and a secure route for any necessary documents. A treatment plan should follow a review of the person’s needs, including the reasons for seeking care and any concerns about the proposed intervention.

Withdrawal management needs a clear account of clinical capabilities. Ask which substances and medical presentations the program accepts, which require another service first, and what emergency transfer arrangements apply. Someone with a history of difficult withdrawal, a significant physical illness, or changing psychiatric symptoms needs individualized medical advice before traveling. The provider’s use of the word detox does not answer those questions. Obtain agreement between the current clinician and the receiving team where a transfer is involved, and establish who is responsible for medical decisions before arrival, throughout the stay, and when care moves elsewhere.

The proposed residence and everyday arrangements

The official property page reviewed provided little usable descriptive information about the current premises. Request a recent tour or a detailed description of the actual residence, with the proposed bedroom, bathroom arrangement, accessibility, and shared spaces identified. Do not assume that the accommodation is private, ensuite, or suitable for a particular mobility need. Ask how many residents are present and whether treatment occurs within the same property. These details help distinguish a booked room from the broader experience suggested by retreat marketing and allow a prospective resident to judge whether the living arrangements are practical.

Clarify meals, laundry, internet access, visiting arrangements, and any restrictions during the early stage of the program. The provider’s FAQ discusses reduced phone access during detox and later use of personal devices, but the current policy should be confirmed for the individual admission. If work or family contact is important, agree a realistic arrangement before travel. The ability to bring a laptop does not establish that normal work commitments can continue. A written daily schedule can show how appointments, groups, rest, and personal responsibilities would fit together.

Therapy beyond the cannabis intervention

Ask the program to describe the psychotherapy and support that accompany its central intervention. Useful details include the language of treatment, the number of individual appointments, who leads groups, and how goals are reviewed with the resident. If trauma, depression, anxiety, or another mental health concern is part of the reason for seeking help, establish whether a clinician with the relevant expertise will assess it. A broad statement about treating underlying issues is less informative than a plan showing the actual appointments and responsibilities. The same questions apply when comparing other programs with a different treatment philosophy.

Consider what you would want to carry back into everyday life. A resident may need support with relationships, routines, appointments, or finding appropriate care close to home. Ask how those goals appear in the program and whether they are reviewed before departure. If group participation or a particular activity is uncomfortable, find out how alternatives are considered. A decision to enter treatment should involve understanding the expected work and the available support, not simply purchasing a stay in an attractive setting. Personal preferences matter alongside the clinical assessment and the program’s actual capabilities.

Prices and financial terms

At the October 20, 2026 review, the Go Green Project X listing on Recovery.com displayed an estimated cost of €29,500 for 30 days. This is a third-party estimate, rather than a current provider quotation or a calendar-month tariff. No currency conversion is needed to understand the listed basis. Ask the provider for a dated price in the currency you will actually pay, identifying the accommodation, clinical appointments, products, transfers, and other services included. If treatment length changes following assessment, request an updated estimate before making financial commitments.

Read the proposed agreement carefully enough to understand deposits, cancellation, early departure, additional medical care, and any continuing support fees. Ask which legal entity will issue the invoice and handle a concern about the service. If payment is being made by a family member, establish the limits of that person’s involvement and how the resident’s clinical information will be protected. Private payment should not be assumed to include every medical consultation or emergency expense. A clear account of responsibilities is especially useful when the resident and the contracting business are based in different countries.

Travel and the period after treatment

Before arranging an international stay, discuss travel fitness and medication continuity with the appropriate clinicians. Ask the provider who can advise on the lawful supply and use of any proposed prescription during the stay and after returning home. Rules and access can differ between countries, so do not assume that a treatment available in Greece can continue unchanged elsewhere. The practical question is how the receiving program and the home clinician will coordinate, including records, prescriptions, and follow-up. Any proposed transition should be understood before the person becomes dependent on arrangements they cannot maintain after departure.

The provider describes aftercare, but ask what that means in appointments, staff contact, duration, and cost. Clarify whether it is clinical follow-up, general recovery support, or a referral to another service. If you return to another country, confirm how local professionals will be involved and what to do if concerns arise between appointments. A useful plan names the next point of contact and explains how information is transferred with consent. It should also address what happens if the proposed cannabis-based intervention is not continued, rather than assuming that the same approach will remain available indefinitely.

Information to obtain before deciding

The Cannabis Project publishes the Greek contact number +30 21 1198 5985 and the email address [email protected] on its contact page. Use an inquiry to establish the exact premises, responsible clinicians, current clinical scope, evidence supporting the proposed intervention, and written financial terms. Discuss those answers with an independent treating professional before choosing this program. The listing provides a starting point for research; the decision requires more specific information than the current public website establishes about the individual care that would be delivered.